SAN DIEGO, July 29, 2020 /PRNewswire/ -- Halozyme
Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update
Conference Call for the second quarter 2020 on Monday, August 10 at 4:30
p.m. ET / 1:30 p.m. PT. Dr.
Helen Torley, president and chief
executive officer, will lead the call. On the same date, Halozyme
will release financial results for the second quarter ended
June 30, 2020, following the close of
trading.
To register for this conference call, please use this link:
http://www.directeventreg.com/registration/event/6277618. After
registering, you will receive an email confirmation that includes
dial in details and unique conference call codes for entry.
Registration is open through the live call. However, to ensure you
are connected for the full call, we suggest registering a day in
advance or at minimum 10 minutes before the start of the call.
The call will be webcast live through the "Investors" section of
Halozyme's corporate website and a recording will be made available
following the close of the call. To access the webcast and
additional documents related to the call, please visit the
Investors page of www.halozyme.com approximately 15 minutes prior
to the call to register, download and install any necessary audio
software. A telephone replay will be available for two weeks after
the call by dialing (800) 585-8367 (domestic callers) or (416)
621-4642 (international callers) using replay ID number
6277618.
About Halozyme
Halozyme Therapeutics, Inc. is a biopharma technology platform
company that provides innovative and disruptive solutions with the
goal of improving patient experience and outcomes. Our proprietary
enzyme rHuPH20 is used to facilitate the delivery of injected drugs
and fluids. We license our technology to biopharmaceutical
companies to collaboratively develop products that combine our
ENHANZE® drug delivery technology with the
collaborators' proprietary compounds. Halozyme is headquartered in
San Diego. For more information
visit www.halozyme.com.
Contact:
Al
Kildani
Vice President, Investor Relations and Corporate Communications
858-704-8122
ir@halozyme.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/halozyme-to-host-second-quarter-2020-financial-results-webcast-and-conference-call-301102395.html
SOURCE Halozyme Therapeutics, Inc.